What Is UthPeak®?
First NMNH with Self-GRAS status for use in
select foods, supplements, & medical foods.
UthPeak® NMNH (Reduced NMN) is a patent-pending crystalline NMNH, a reduced form of nicotinamide mononucleotide (NMN), a potentially more potent NAD+ booster than mainstream market-available NAD+ precursors. UthPeak® NMNH (Reduced NMN) has successfully completed preclinical studies and Phase I clinical trials and is now undergoing Phase II clinical studies to further validate its efficacy in supporting various health benefits.
UthPeak® Clinical Agenda
2023
Toxicology Testing Completed
2024
Phase I Clinical Trial Completed
2025
Phase II - Clinical Trial
In a 90-day double-blind, placebo-controlled, randomized clinical study involving 80 healthy participants, the safety, tolerability, and pharmacokinetics of UthPeak® NMNH (reduced NMN) were assessed. The results indicated promising safety outcomes, alongside a significant increase in NAD+ levels and a decrease in biological age indicators. Participants also reported enhanced emotional well-being and energy support throughout the study duration.
Building on findings from both in vitro and in vivo tests, NMNH (reduced NMN) demonstrates potential health benefits that extend beyond animal models. This will be a primary focus for UthPeak™'s research and development efforts in the upcoming phase II clinical trials scheduled for 2025, highlighting the brand's commitment to scientific advancement in health and wellness.
Anti-Aging
UthPeak® stands at the forefront of anti-aging science as a high-purity form of NMNH, directly elevating NAD+ levels to combat age-related decline and promote cellular repair and resilience
Cardiovascular Health Promoting
UthPeak® is a champion for heart health by directly supporting cardiovascular functions. It contributes significantly to maintaining healthy blood vessels, supporting heart muscle health, and promoting better blood flow.
Energy Boost
UthPeak® enhances mitochondrial function, the energy factories within your cells, ensuring a consistent and long-lasting surge of energy.
Brain Function Enhancement
UthPeak® contributes to improved brain function by improving neuronal energy production and maintenance. This can lead to enhanced cognitive functions, including improved memory, focus, and overall mental clarity.
Sleep Quality Improvement
By supporting cellular health and maintaining proper metabolic balance, UthPeak® contributes to improved sleep quality. Healthier cells and balanced energy levels can help normalize sleep patterns, leading to more restful and restorative sleep.
Weight Management
While direct evidence linking UthPeak® to weight management is still under exploration, its role in regulating metabolism may suggest potential benefits. By supporting metabolic balance, UthPeak® could potentially help manage weight effectively as part of a healthy lifestyle.
UthPeak®, A Patent-Pending Stabilized Form of NMNH (Reduced NMN)
With UthPeak® 's patented crystalline technology spanning 20 countries worldwide, prepare to strategize your brand and product offerings by harnessing tomorrow's health ingredient ROCK STAR. Outshine your competitors by entering the new epoch of super NAD+ boosters.
NMNH Supplement Manufacturing and Supplying Methodology
What EffePharm R&D Director Says About UthPeak®?

"We believe that NMNH (Reduced NMN) could be the next star NAD+ booster. We have observed a great deal of potential in this ingredient through animal models in the lab. If these benefits can be confirmed and extended to human beings, we stand to benefit significantly as an aging population. At EffePharm, we exclusively invest in cutting-edge ingredients with verified benefits because we believe in EFFECTIVE NUTRITION. This is what enables us to lead more fulfilling and creative lives. The global success of Uthever® has demonstrated that our efforts can profoundly impact consumers' lives. We are committed to continuing to create value for users of UthPeak®."
--- Dr. Jianjun YU, EffePharm R&D Director